Company news

Neuronetics, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Neuronetics Receives MDSAP Certification and CE Mark Certification under New MDR

May 7, 2023

Neuronetics Announces Lisa Metzner-Rosas as SVP, Chief Marketing Officer

April 30, 2023

Neuronetics Announces Expanded TMS Access through United HealthCare

April 27, 2023

Neuronetics Announces Continued Momentum for Expanded Health Insurance Coverage for TMS Therapy

April 12, 2023

Neuronetics Secures Up To $60 Million in New Debt Financing with SLR Capital Partners, Provides Greenbrook TMS with $6.0 Million Promissory Note

April 3, 2023

Neuronetics Reports Record Fourth Quarter and Record Full Year 2022 Financial and Operating Results

March 6, 2023

Neuronetics Announces TMS Coverage Criteria Changes for Over 23 Million Covered Lives

March 1, 2023

Neuronetics Expands NeuroStar® Advanced Therapy’s Proprietary TrakStar® Platform

February 22, 2023

Neuronetics Announces Elevation of Sara Grubbs to SVP, Chief Revenue Officer

February 15, 2023

Neuronetics Announces Updated Medicare Policy Expanding Access to NeuroStar TMS Therapy through Nurse Practitioners

February 9, 2023

Neuronetics and Greenbrook TMS Announce Six Year Exclusive Partnership

January 18, 2023

Neuronetics Announces Data Confirming Efficacy in Treating Anxious Depression with NeuroStar® Advanced Therapy for Mental Health

January 16, 2023

Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2022 Financial Results

January 8, 2023

Neuronetics Announces Appointment of Joseph H. Capper to its Board of Directors

December 28, 2022

Neuronetics Announces NeuroStar® Advanced Therapy for Mental Health System Innovations

November 13, 2022

Neuronetics Reports Third Quarter 2022 Financial and Operating Results

November 7, 2022

Neuronetics Announces Updated TMS Coverage Policies That Will Expand Patient Access to NeuroStar TMS Therapy for Mental Health

October 24, 2022

Neuronetics Launches Innovations To NeuroStar® Advanced Therapy’s Proprietary TrakStar® Platform

September 25, 2022

Neuronetics, Inc. Announces Grand Opening of NeuroStar® University with Ribbon-Cutting Ceremony

September 12, 2022

Neuronetics Announces 510(k) Clearance of D-Tect™ MT Accessory for NeuroStar® Advanced Therapy for Mental Health

August 28, 2022

Neuronetics Reports Second Quarter 2022 Financial and Operating Results

August 1, 2022

Neuronetics and Alleviant Health Centers Announce Exclusive Partnership

July 24, 2022

NeuroStar® Advanced Therapy for Mental Health Receives FDA Clearance for Treatment of Anxious Depression

July 18, 2022

Neuronetics Announces Positive TMS Coverage Policies to Expand Patient Access to NeuroStar TMS Therapy for Mental Health

July 10, 2022

Neuronetics Reports First Quarter 2022 Financial and Operating Results

May 11, 2022

Neuronetics and Transformations Care Network Announce Extended Commercial Partnership

May 10, 2022

NeuroStar® Advanced Therapy for Mental Health Receives FDA Clearance for Treatment of Obsessive-Compulsive Disorder

May 9, 2022

Neuronetics Reports Fourth Quarter and Full Year 2021 Financial and Operating Results

March 7, 2022

NeuroStar® Advanced Therapy Launches New “Tap Into a New Possibility” Campaign for Depression Awareness

March 2, 2022

Neuronetics Announces Amendment of Credit Facility with SLR Investment Corp.

February 21, 2022

Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2021 Financial Results

January 9, 2022

Neuronetics Announces 510(k) Clearance of MT Cap Technology for NeuroStar® Advanced Therapy for Mental Health

December 19, 2021

Neuronetics Announces Key Role for NeuroStar Advanced Therapy at 4th International Brain Stimulation Conference

December 5, 2021

Neuronetics Reports Third Quarter 2021 Financial and Operating Results

November 8, 2021

Neuronetics and River Region Psychiatry Announce Exclusive Partnership

November 7, 2021

Neuronetics Celebrates 235,000 Treatment Milestone for Success TMS

October 25, 2021

Neuronetics Launches Upgrades of NeuroStar® Advanced Therapy for Mental Health

October 18, 2021

CORRECTION - Neuronetics Announces Preliminary Revenue for Third Quarter 2021

October 18, 2021

Neuronetics Announces Preliminary Revenue for Third Quarter 2021

October 11, 2021

Neuronetics Announces Commercial Agreement with Success TMS

October 4, 2021

Neuronetics and Zion Healing Announce First Franchise Model for TMS Clinics

September 6, 2021

Neuronetics Announces Appointment of Megan Rosengarten to its Board of Directors

August 4, 2021

Neuronetics Reports Second Quarter 2021 Financial and Operating Results

August 2, 2021

Neuronetics Launches Enhanced Digital Resource Center for NeuroStar Providers

July 13, 2021

Neuronetics Unveils New Clinical Data at Clinical TMS Society 2021 Annual Meeting

June 8, 2021

Neuronetics Names Todd Cushman as Vice President, Business Development

May 31, 2021

Neuronetics® Celebrates 100,000 Treatment Milestone for Southern California TMS Center

May 16, 2021

Neuronetics Reports First Quarter 2021 Financial and Operating Results

May 3, 2021

Neuronetics Announces Retirement of Brian Farley and Appointment of Robert Cascella as Chairman of its Board of Directors

April 13, 2021

Neuronetics Announces Appointment of Robert Cascella to its Board of Directors

March 31, 2021

← Newer news releases · Older news releases →

Calls

The 5 newest of 23 calls. Every call is listed under its year.

Decks

The 5 newest of 14 decks. Every deck is listed under its year.